Dr. Laura Jelliffe-Pawlowski is a Professor in the UCSF School of Medicine and is the Director of Precision Health and Discovery with the UCSF California Preterm Birth Initiative (pretermbirthca.ucsf.edu). She serves as the Primary Investigator for the HOPE COVID-19 study which examines the impact of COVID-19 and pandemic-related hardship on adverse pregnancy and infant outcomes (HOPE.UCSF.edu/covid_19). She is leader and founder of the HOPE Consortium (HOPE.UCSF.edu) which includes investigators from across the US and world whose work focuses on uncovering causes of adverse pregnancy and infant outcomes and identifying in-roads for interventions. She has served as a state, national, and international adviser on committees and task forces focused on the early detection and prevention of preterm birth and developmental disabilities and holds patents for blood tests and algorithms predicting preterm birth.
Precision Metrics and Pregnancy Health: Insights from Pandemic
The COVID-19 pandemic has changed the way many us think about pregnancy and precision health. Critical is the consideration of how metrics can do a better job at identifying those at the highest risk -- especially low-income and Black and Brown pregnant people. Lessons learned and new metrics will be shared.
Aleksandar Rajkovic, UCSF
Kathryn G. Schubert, Society for Women's Health Research
Researchers have long been recognizing the uniqueness of women’s health and its substantial effect on clinical practice, acknowledging the increasing appreciation of the importance of multidisciplinary approaches to health and disease. In every organ system, there are diseases that are unique to women, more common in women than in men, or characterized by differences in disease course in women compared to men. This Track will focus on the following topics related to Women’s Health: